BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22310967)

  • 21. Etanercept: an evolving role in psoriasis and psoriatic arthritis.
    Prodanovich S; Ricotti C; Glick BP; Inverardi L; Leonardi CL; Kerdel F
    Am J Clin Dermatol; 2010; 11 Suppl 1():3-9. PubMed ID: 20586498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imported case of visceral leishmaniasis presenting as pancytopenia in a Norwegian patient treated with methotrexate and etanercept for psoriasis arthritis.
    Besada E; Njålla RJ; Nossent JC
    Rheumatol Int; 2013 Oct; 33(10):2687-9. PubMed ID: 22886470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient-reported outcomes in a randomized trial of etanercept in psoriatic arthritis.
    Mease PJ; Woolley JM; Singh A; Tsuji W; Dunn M; Chiou CF
    J Rheumatol; 2010 Jun; 37(6):1221-7. PubMed ID: 20395648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A preliminary study of etanercept in the treatment of severe, resistant psoriatic arthritis.
    Yazici Y; Erkan D; Lockshin MD
    Clin Exp Rheumatol; 2000; 18(6):732-4. PubMed ID: 11138337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Etanercept therapy for patients with psoriatic arthritis and concurrent hepatitis C virus infection: report of 3 cases.
    Magliocco MA; Gottlieb AB
    J Am Acad Dermatol; 2004 Oct; 51(4):580-4. PubMed ID: 15389194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness and safety of etanercept in patients with psoriatic arthritis in a Canadian clinical practice setting: the REPArE trial.
    Gladman DD; Bombardier C; Thorne C; Haraoui B; Khraishi M; Rahman P; Bensen W; Syrotuik J; Poulin-Costello M
    J Rheumatol; 2011 Jul; 38(7):1355-62. PubMed ID: 21572156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psoriatic arthritis: a guide for dermatology nurses.
    Gottlieb AB
    Dermatol Nurs; 2003 Apr; 15(2):107-10, 113-8; quiz 119. PubMed ID: 12751345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Etanercept plus ciclosporin versus etanercept plus methotrexate for maintaining clinical control over psoriatic arthritis: a randomised pilot study.
    Atzeni F; Boccassini L; Antivalle M; Salaffi F; Sarzi-Puttini P
    Ann Rheum Dis; 2011 Apr; 70(4):712-4. PubMed ID: 20810394
    [No Abstract]   [Full Text] [Related]  

  • 29. Etanercept for severe psoriasis and psoriatic arthritis: observations on combination therapy.
    Iyer S; Yamauchi P; Lowe NJ
    Br J Dermatol; 2002 Jan; 146(1):118-21. PubMed ID: 11841377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of psoriatic arthritis with etanercept, methotrexate, and cyclosporin A.
    Gül U; Gönül M; Kiliç A; Erdem R; Cakmak SK; Gündüz H
    Clin Ther; 2006 Feb; 28(2):251-4. PubMed ID: 16678646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Follow-up of psoriatic arthritis mutilans patients treated with anti-TNF-alpha therapy.
    Pomerantz RG; Mody E; Husni ME; Qureshi AA
    J Drugs Dermatol; 2009 Apr; 8(4):406-12. PubMed ID: 19363860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimating the cost and health status consequences of treatment with TNF antagonists in patients with psoriatic arthritis.
    Bansback NJ; Ara R; Barkham N; Brennan A; Fraser AD; Conway P; Reynolds A; Emery P
    Rheumatology (Oxford); 2006 Aug; 45(8):1029-38. PubMed ID: 16782734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-approval trials of new medicines: widening use or deepening knowledge? Analysis of 10 years of etanercept.
    van Luijn JC; Danz M; Bijlsma JW; Gribnau FW; Leufkens HG
    Scand J Rheumatol; 2011 May; 40(3):183-91. PubMed ID: 20858147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of etanercept as a non-surgical treatment for temporomandibular joint psoriatric arthritis: a case report.
    Lamazza L; Guerra F; Pezza M; Messina AM; Galluccio A; Spink M; De Biase A
    Aust Dent J; 2009 Jun; 54(2):161-5. PubMed ID: 19473159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapy of psoriasis vulgaris and psoriatic arthritis with etanercept].
    Mrowietz U; Barth J; Boehncke WH; Rosenbach T; Wozel G
    J Dtsch Dermatol Ges; 2005 Jun; 3(6):470-2. PubMed ID: 15892851
    [No Abstract]   [Full Text] [Related]  

  • 36. Resolution of idiopathic recurrent pericarditis in a psoriatic arthritis patient treated with etanercept.
    Esposito M; Giunta A; Babino G; Schipani C; Marchei M; Chimenti MS
    Eur J Dermatol; 2012; 22(1):151-2. PubMed ID: 22155373
    [No Abstract]   [Full Text] [Related]  

  • 37. Etanercept (Enbrel): update on therapeutic use.
    Spencer-Green G
    Ann Rheum Dis; 2000 Nov; 59 Suppl 1(Suppl 1):i46-9. PubMed ID: 11053088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Etanercept, anticytokines and mania.
    Kaufman KR
    Int Clin Psychopharmacol; 2005 Jul; 20(4):239-41. PubMed ID: 15933486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of psoriatic arthritis therapies.
    Gladman DD
    Semin Arthritis Rheum; 2003 Aug; 33(1):29-37. PubMed ID: 12920694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Psoriasis and psoriatic rheumatism: effectiveness of etanercept for cutaneous and joint lesions].
    Paul C; Solignac M
    Ann Dermatol Venereol; 2010 Apr; 137(4 Suppl):13-5. PubMed ID: 20510165
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.